PreveCeutical issues 784,000 advisory commission warrants at exercise price of $0.05

• Preveceutical Medical issued 4,000,000 share purchase warrants in a third tranche of its private placement, priced at $0.025 per unit.
• Each warrant is exercisable at $0.05 for two years from the June 12, 2026 closing, subject to early expiry if shares trade at $0.10 for 10 days.
• The company also issued 784,000 advisory commission warrants, exercisable at $0.05 on the same terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Preveceutical Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607271712NEWSFILECNPR____20260727_306782_1) on July 27, 2026, and is solely responsible for the information contained therein.